Relapse in the first 8 weeks after onset of COVID-19 disease in outpatients: Viral reactivation or inflammatory rebound?

Maaike Buskermolen: Department of Infectious Disease Control, Municipal Public Health Service Rotterdam-Rijnmond, Rotterdam, Netherlands. Electronic address: m.buskermolen@rotterdam.nl.
Karlijn Te Paske: Department of Infectious Disease Control, Municipal Public Health Service Utrecht, Utrecht, Netherlands.
Janko van Beek: Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Titia Kortbeek: Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Hannelore Götz: Department of Infectious Disease Control, Municipal Public Health Service Rotterdam-Rijnmond, Rotterdam, Netherlands; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Ewout Fanoy: Department of Infectious Disease Control, Municipal Public Health Service Rotterdam-Rijnmond, Rotterdam, Netherlands.
Sabiena Feenstra: Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Jan Hendrik Richardus: Department of Infectious Disease Control, Municipal Public Health Service Rotterdam-Rijnmond, Rotterdam, Netherlands; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Albert Vollaard: Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.

OpenLB
Open Library of Bioscience